Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Accord
Pharma
Hospira, Accord recall their drugs for separate issues
Right before the New Year, Pfizer's Hospira and Accord were faced with drug recalls.
Zoey Becker
Jan 4, 2023 2:06pm
In appeal, Advanz calls UK fine 'manifestly wrong'
Sep 27, 2022 3:48pm
Hospira must wait to launch generic Lexiscan—but only two weeks
Sep 26, 2022 2:11pm
AstraZeneca escapes 1 of 2 Seroquel pay-for-delay claims
Jul 8, 2022 11:58am
In flurry of activity, EMA issues nods for Sanofi, Lilly drugs
May 20, 2022 10:46am
Former Sanofi and BMS plants in EU reopened by Asian drugmakers
Jan 30, 2018 9:06am
